Centerstone Investors LLC Sells 60,932 Shares of Henry Schein, Inc. $HSIC

Key Points

• Centerstone Investors LLC reduced its stake in Henry Schein, Inc. by 86% in Q1, selling 60,932 shares and leaving them with 9,914 shares, making it the company's 15th largest holding.
• Henry Schein reported earnings of $1.10 per share for the last quarter, missing estimates by $0.09, while achieving a 3.3% year-over-year revenue growth to $3.24 billion.
• Recent analyst ratings show a shift in sentiment with several price targets lowered, and a consensus rating of "Hold," alongside a price target of $76.67.

Centerstone Investors LLC cut its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 86.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,914 shares of the company's stock after selling 60,932 shares during the quarter. Henry Schein accounts for 1.6% of Centerstone Investors LLC's portfolio, making the stock its 15th biggest holding. Centerstone Investors LLC's holdings in Henry Schein were worth $679,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Investment Management Corp VA ADV acquired a new stake in Henry Schein during the fourth quarter worth about $32,000. Rakuten Securities Inc. bought a new position in Henry Schein during the first quarter worth about $34,000. Whittier Trust Co. lifted its stake in Henry Schein by 714.3% during the first quarter. Whittier Trust Co. now owns 798 shares of the company's stock worth $55,000 after purchasing an additional 700 shares during the period. Quarry LP bought a new position in Henry Schein during the first quarter worth about $71,000. Finally, UMB Bank n.a. lifted its stake in Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Trading Down 2.4%

Shares of Henry Schein stock traded down $1.69 on Monday, hitting $67.74. 1,512,871 shares of the company's stock traded hands, compared to its average volume of 1,751,953. The firm's 50-day moving average price is $69.92 and its two-hundred day moving average price is $69.68. The stock has a market capitalization of $8.21 billion, a PE ratio of 21.85, a price-to-earnings-growth ratio of 2.29 and a beta of 0.86. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). The business had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business's revenue was up 3.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Barrington Research cut their price target on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a research note on Wednesday, August 6th. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. UBS Group cut their price target on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a research note on Wednesday, August 6th. Stifel Nicolaus reiterated a "hold" rating and issued a $75.00 target price (down previously from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Finally, Robert W. Baird reiterated a "neutral" rating and issued a $72.00 target price (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Five analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $76.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.